Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2017-03-27

Clinical Trial Update: Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.

View source ↗

Summary

Clinical trial update describing surveillance for early liver injuries associated with Xianlin Gubao Pill.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xianlin Gubao Pill

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Drug-Induced Liver Injury | Status: UNKNOWN